| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines Ltd. (ONC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 83 sells. ONC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.58M | $1.25B | - | |
| Pres | 1.45M | $394.50M | - | |
| VP | 97.0K | $26.37M | - | |
| CEO | 3.3K | $888.2K | - | |
| Dir | 2.6K | $714.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2020 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 5,000 | $260.27 | $1,301,355.95 | -98.3% | |
| Sep 16, 2020 | Oyler John59 | Chief Executive Officer | Sell | 81,228 | $253.46 | $20,587,969.07 | -34.2% | |
| Sep 14, 2020 | Liang Howard59 | CFO &Chief Strategy Officer | Sale+OE | 14,000 | $250.27 | $3,503,763.52 | -29.6% | |
| Sep 3, 2020 | Huang Jane81 | CMO, Hematology | Sell | 3,128 | $233.07 | $729,045.04 | -50.5% | |
| Sep 2, 2020 | Oyler John59 | Chief Executive Officer | Sell | 61,042 | $233.21 | $14,235,597.46 | -23.4% | |
| Aug 28, 2020 | Huang Jane81 | CMO, Hematology | Sale+OE | 3,000 | $242.21 | $726,626.31 | -35.3% | |
| Aug 21, 2020 | Oyler John59 | Chief Executive Officer | Sell | 92,177 | $237.06 | $21,851,789.34 | -26.2% | |
| Aug 14, 2020 | Oyler John59 | Chief Executive Officer | Sell | 5,115 | $210.27 | $1,075,505.71 | -33.8% |